Clinical Hypertension 2022 Impact Factor : 4.2
You can find more details about journal's 2022 Impact Factor here.
You can find more details about journal's 2022 Impact Factor here.
Check out new article collections in Clinical Hypertension.
Although antihypertensive drug therapy is commonly believed to be a life-long therapy, several recent guidelines have suggested that antihypertensive medications can be gradually reduced or discontinued for some patients whose blood pressure (BP) is well-controlled for an extended period. Thus, this pilot study aimed to describe the success rate of antihypertensive drug discontinuation over 6 months among young and middle-aged patients with hypertension.
Hae-Young Lee & Kyoung Suk Lee
Clinical Hypertension volume 29, Article number: 1 (2023)
The study show the importance of CBP measurements in T2DM patients and present a cutoff value for ASCVD events and hypertension-induced complications.
Min-Sik Kim, Seon-Ah Cha & Gee-Hee Kim
Clinical Hypertension volume 28, Article number: 31 (2022)
Clinical Hypertension is a continuation of the Journal of the Korean Society of Hypertension, formerly published by IB Planning Co. All previous content(1995-2014) from the Journal of the Korean Society of Hypertension is freely available at its official website.
Affiliated with the Korean Society of Hypertension, Clinical Hypertension publishes in all areas of hypertension, pulmonary hypertension and vascular disorders including vascular biology, pharmacology, pediatric hypertension and imaging. Articles published in Clinical Hypertension also encompass other disciplines such as neuroscience, endocrinology, nephrology, rheumatology and nursing. Our expert Editorial Board welcomes submissions from across our subject area, and we pride ourselves on providing a swift editorial response.
Clinical Hypertension is the official journal of Korean Society of Hypertension (KSH).
KSH sponsors full amount of APC for all the articles accepted for publication so that the authors do not need to pay.
All previous contents (1995-2014) from the Journal of the Korean Society of Hypertension are freely available at its official website.
Wook-Bum Pyun
Prof. PYUN is Professor of Medicine at Ewha Womans University, School of Medicine, Seoul Hospital, Seoul, Korea. He gained his MD degree at Yonsei University College of Medicine in Seoul, Korea and was awarded a PhD in medical science by Yonsei University. He had been served as deputy editor of Korean Circulation Journal, the official journal of Korean Society of Cardiology for more than 10 years and is immediate past president of Korean Society of Hypertension. His research interests primarily focus on blood pressure monitoring, cuff-less blood pressure measurement and renal denervation in difficult to control blood pressure
See the list of Editorial Board members.
In response to the growing need for revision of the hypertension treatment guideline, the Guideline Committee of the Korean Society of Hypertension have written their updated guidelines for the management of hypertension. The articles cover epidemiology, diagnosis and treatment and treatment of hypertension, and hypertension in special situations.
We are pleased to announce that all articles published in Clinical Hypertension journal are covered and indexed in PubMed, PubMed Central, Web of Science (ESCI), Scopus, EMBASE, Google Scholar, Proquest, KoreaMed, CAS and DOAJ.
Clinical Hypertension is the official journal of the Korean Society of Hypertension, and the Korean Pulmonary Hypertension Society.
The Society is currently covering all publication costs so there are no article processing charges for authors.
2022 Citation Impact
4.2 - 2-year Impact Factor
1.756 - SNIP (Source Normalized Impact per Paper)
0.999 - SJR (SCImago Journal Rank)
2022 Speed
13 days submission to first editorial decision for all manuscripts (Median)
168 days submission to accept (Median)
2022 Usage
271,472 downloads
301 Altmetric mentions